The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

L&T Technology Services (BSE: 540115, NSE: LTTS) hat die Markteinführung von PLxAI angekündigt. Dabei handelt es sich um das firmeneigene GenAI-basierte Framework ...

The World Bank Group is committed to meeting the needs of developing countries with smart development solutions. We are supporting countries to build resilience to climate change so that they are less ...